Background
Metabolic derangements, inflammation, colorectal cancer, CRC
METABOLIC DERANGEMENT, COLORECTAL CANCER, INFLAMMATION
Metabolic derangements and systemic inflammation are related to the progression of colorectal cancer (CRC) and the prognoses of these patients. The survival of stage II and III CRC patients existed considerable heterogeneity highlighting the urgent need for new prediction models. This study aimed to develop and validate prognostic nomograms based on preoperative serum liver enzyme as well as evaluate the clinical utility.